Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Yasmin Mashhoon"'
Autor:
Stephan Ortiz, Sean J. Pittock, Achim Berthele, Michael Levy, Ichiro Nakashima, Celia Oreja-Guevara, Kerstin Allen, Yasmin Mashhoon, Becky Parks, Ho Jin Kim
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
ObjectiveTo assess the pharmacokinetics and pharmacodynamics of the long-acting terminal complement 5 (C5) inhibitor ravulizumab in adults with anti-aquaporin-4 antibody-positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD) in the phase 3,
Externí odkaz:
https://doaj.org/article/b548b047f2a84fcfb67d42e621a2f960
Autor:
Sean J. Pittock, Michael Barnett, Jeffrey L. Bennett, Achim Berthele, Jérôme de Sèze, Michael Levy, Ichiro Nakashima, Celia Oreja‐Guevara, Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, Marcus Yountz, Kerstin Allen, Yasmin Mashhoon, Ho Jin Kim
Publikováno v:
Annals of Neurology. 93:1053-1068
OBJECTIVE: CHAMPION-NMOSD (NCT04201262) is a phase 3, open-label, externally controlled interventional study evaluating the efficacy and safety of the terminal complement inhibitor ravulizumab in adult patients with anti-aquaporin-4 antibody-positive
Autor:
Sean Pittock, Michael Barnett, Jeffrey Bennett, Achim Berthele, Jérôme de Sèze, Michael Levy, Ichiro Nakashima, Celia Oreja Guevara, Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, Kerstin Allen, Yasmin Mashhoon, Marcus Yountz, Ho Jin Kim
Publikováno v:
Sunday, April 23.
Autor:
Michael Levy, Sean Pittock, Michael Barnett, Jeffrey Bennett, Achim Berthele, Jerome De Seze, Ichiro Nakashima, Celia Oreja Guevara, Jacqueline Palace, Friedemann Paul, Carlo Pozzilli, Kerstin Allen, Yasmin Mashhoon, Marcus Yountz, Ho Jin Kim
Publikováno v:
Sunday, April 23.
Publikováno v:
Neurology. 99:S4-S5
ObjectiveTo present the design and rationale for the phase 3 trial ALXN-1210-NMO-307 (NCT04201262).BackgroundEculizumab is a complement component 5 (C5) inhibitor approved for adults with anti-aquaporin-4 antibody-positive (AQP4+) neuromyelitis optic
Publikováno v:
Pediatric clinics of North America. 66(6)
As an increasing number of states legalize cannabis use for recreational and/or medical purposes, it is increasingly important to understand the neural and cognitive consequences of recreational cannabis use in adolescent consumers. Adolescence is ma
Autor:
Kanchana Jagannathan, Heather Pater, Reagan R. Wetherill, Anna Rose Childress, Teresa R. Franklin, Nathan Hager, Yasmin Mashhoon
Publikováno v:
Cannabis and Cannabinoid Research
Addiction theories posit that addiction is the result of a progressive transition from voluntary to habitual, compulsive drug use—changes that have been linked, in animals, to a shift from ventral to dorsal striatal control over drug-seeking behavi
Publikováno v:
The American Journal on Addictions. 25:105-109
Background and Objectives Stimuli that are repeatedly paired with substance use, such as drug paraphernalia, can themselves elicit drug craving. The aim of this study was to examine whether particular cue types elicit greater craving responses than o
Publikováno v:
Drug and Alcohol Dependence. 155:275-283
The prevalence of marijuana (MJ) use among youth and its legalization for medical or recreational use has intensified public health endeavors of understanding MJ effects on brain structure and function. Studies indicate that MJ use is related to impa
Publikováno v:
Brain research. 1687
Adolescence is a period during which a number of critical neuromaturation processes occur and the vulnerability for developing nicotine dependence is extremely high. Thus, early-onset (EO; age 16 years old), relative to late-onset (LO; age ≥ 16 yea